Mirae Asset Global Etfs Holdings Ltd. Ionis Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 9,450 shares of IONS stock, worth $319,504. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,450
Previous 7,825
20.77%
Holding current value
$319,504
Previous $313,000
5.43%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$557 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$479 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$388 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$349 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$293 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.8B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...